Achieve Life Sciences, Inc. Grants Receivable, Current
Achieve Life Sciences, Inc. (ACHV) had Grants Receivable, Current of $111.00 thousand as of 2023-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Notes
us-gaap:GrantsReceivableCurrent · last filed 2025-03-11
- 2023-12-31: Grants Receivable, Current $111.00K.
- 2023-09-30: Grants Receivable, Current $83.00K.
- 2023-06-30: Grants Receivable, Current $350.00K.
- 2023-03-31: Grants Receivable, Current $89.00K.
| Period end | Grants Receivable, Current |
|---|---|
| 2023-12-31 | $111.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $83.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $350.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $89.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $105.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $145.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $313.00K 10-Q · filed 2022-08-11 |
| 2021-12-31 | $153.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $151.00K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |